Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Method for In Vitro Neuron Culture Will Advance Serotonin Research

By LabMedica International staff writers
Posted on 24 Aug 2015
A method has been developed that enables human serotonin-producing neurons, generated from transformed fibroblasts, to be grown in culture for use as a tool for research and drug discovery on many serotonin-related mental disorders.

Serotonergic (5HT) neurons exert diverse and widespread functions in the brain. More...
Malfunctions of the serotonergic system give rise to a variety of mental illnesses including depression, anxiety, obsessive compulsive disorder, autism, and eating disorders. Up to now, it has not been possible to grow cultures of human serotonin-producing neurons in the laboratory, so studies have been carried out on animals.

A technological breakthrough devised by researchers at the University at Buffalo (NY, USA) has changed this picture. They demonstrated a method for directly converting human primary fibroblasts into induced serotonergic (i5HT) neurons. This was accomplished by growing fibroblasts in medium to which the genes for the proteins Ascl1 (Achaete-scute homolog 1), Foxa2 (forkhead box protein A2), Lmx1b (LIM homeobox transcription factor 1-beta), and FEV (a gene exclusively expressed in neurons of the central serotonin (5-HT) system) had been added. The transformation process was enhanced by inhibiting the gene for p53 and maintaining appropriate culture conditions including hypoxia.

Results published in the July 28, 2015, online edition of the journal Molecular Psychiatry revealed that the i5HT neurons expressed markers for mature serotonergic neurons, had calcium ion dependent 5HT release and selective 5HT uptake, exhibited spontaneous action potentials and spontaneous excitatory postsynaptic currents. Application of serotonin significantly increased the firing rate of spontaneous action potentials, demonstrating the functional utility of i5HT neurons for studying serotonergic neurotransmission.

“This research shows that it is possible to convert one type of cell into other types that have been difficult to access, such as neurons or heart cells,” said senior author Dr. Jian Feng, professor of physiology and biophysics at the University at Buffalo. “All we need to do is find out the combination of transcription factors that is necessary. Sooner or later, we will find out what those combinations are so that we can regenerate cells and eventually tissues that will mimic the real cells and tissues in the body.”

“These patient-specific serotonin neurons will be very useful to the discovery of new drugs for diseases ranging from depression and anxiety to obsessive-compulsive disorder and many others,” said Dr. Feng. “They will not only allow researchers to study why certain individuals develop a disease but also to find out what can be done to treat it.”

Related Links:

University at Buffalo



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.